Q2 2025
Released Aug 13, 2025, before the open
10-Q filed Aug 13, 2025, 44 days after period end · 0001789769-25-000081
Q2 2025 · 10-Q
Revenue—
Net Income-$21.39M-$21.39M N/M vs Q2 2024N/M vs Q1 2025
EPS Diluted-$3.24-$3.24 N/M vs Q2 2024N/M vs Q1 2025
Operating Income-$23,440,000N/M
Operating Cash Flowderived-$14,791,000N/M
What the release said
The release
Same quarter
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Net Income | -$21.39M | -$14.92M | -$18.66M | -$58.99M |
| EPS Diluted | -$3.24 | -$2.29 | -$2.87 | -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR